LIONHEAD(SH:600539) Zheng Quan Zhi Xing·2025-08-26 14:12Core Viewpoint - The company plans to acquire 97.4399% of Hangzhou Lipo Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds through share issuance to specific management companies [1][2]. Group 1: Transaction Overview - The company’s board approved the transaction on August 7, 2025, and the first extraordinary general meeting of shareholders was held on August 22, 2025, to review the related proposals [2]. - The transaction involves 14 counterparties, including Wang Xulongqi and Deng Haoyu, who hold the majority shares of the target company [1]. Group 2: Updates and Revisions - The company updated the transaction documents due to a change in the review institution to Tianjian Accounting Firm, which issued a review report [2][3]. - The revised report includes updates on the decision-making and approval processes that still need to be fulfilled for the transaction [3][4]. Group 3: Compliance and Financial Information - The revised report also contains updates on the compliance analysis of the transaction and the financial accounting information as per the review report from Tianjian Accounting Firm [5][6]. - The company has conducted a thorough review and self-check of the entire restructuring report, ensuring that minor adjustments do not affect the transaction plan [6].